Ex-Executive at Blood Filter Start-Up Is Charged With Covering Up Deaths
#blood filter #startup #executive #criminal charges #patient deaths #cover-up #medical device #regulatory oversight
📌 Key Takeaways
- Former executive of a blood filter startup faces criminal charges for concealing patient deaths.
- The charges relate to alleged failure to report fatal incidents linked to the company's medical device.
- The case highlights regulatory oversight issues in the medical technology industry.
- Legal action underscores potential risks of corporate misconduct in healthcare startups.
📖 Full Retelling
ExThera attracted cancer patients to Antigua with the promise that its devices could cure them. Its former chief regulatory officer faces up to three years in prison.
🏷️ Themes
Corporate Fraud, Medical Device Safety
Entity Intersection Graph
No entity connections available yet for this article.
Original Source
The Antigua operation was the brainchild of Alan Quasha, an American billionaire who saw promise in ExThera’s blood filter as a cancer and longevity treatment. His family-owned private equity firm, Quadrant Management, invested in ExThera and created a Caribbean distributor that purchased $10 million worth of filtering devices from the company. Another Quadrant subsidiary employed an Antigua health clinic to administer the treatments.
Read full article at source